HEMODYNAMIC, RENAL, AND HORMONAL RESPONSES TO BRAIN NATRIURETIC PEPTIDE INFUSION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE

被引:393
作者
YOSHIMURA, M
YASUE, H
MORITA, E
SAKAINO, N
JOUGASAKI, M
KUROSE, M
MUKOYAMA, M
SAITO, Y
NAKAO, K
IMURA, H
机构
[1] KUMAMOTO UNIV,SCH MED,DIV CARDIOL,1-1-1 HONJO,KUMAMOTO 860,JAPAN
[2] NATL CARDIOVASC CTR,RES INST,SUITA,OSAKA 565,JAPAN
[3] KYOTO UNIV,SCH MED,DEPT MED,DIV 2,KYOTO 606,JAPAN
关键词
ATRIAL NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CONGESTIVE HEART FAILURE; NATRIURESIS;
D O I
10.1161/01.CIR.84.4.1581
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. This study was designed to examine the hemodynamic, renal, and hormonal effects of brain natriuretic peptide (BNP) infusion in patients with congestive heart failure (CHF) and in control subjects. Methods and Results. We infused synthetic human BNP at a rate of 0.1-mu-g/kg/min. BNP infusion decreased pulmonary capillary wedge pressure (control, from 5 +/- 1 to 2 +/- 1 mm Hg, p < 0.01; CHF, from 21 +/- 3 to 14 +/- 4 mm Hg, p < 0.05) and systemic vascular resistance (control, from 1,264 +/- 75 to 934 +/- 52 dyne.sec.cm-5; CHF, from 2,485 +/- 379 to 1,771 +/- 195 dyne.sec.cm-5; p < 0.01, respectively) and increased stroke volume index (control, from 49.9 +/- 2.7 to 51.5 +/- 2.3 ml/m2, p = NS; CHF, from 25.6 +/- 3.8 to 32.0 +/- 3.9 ml/m2, p < 0.01). BNP infusion significantly increased urine volume (control, from 2.3 +/- 0.7 to 7.5 +/- 1.9 ml/min; CHF, from 0.8 +/- 0.2 to 5.3 +/- 1.0 ml/min; p < 0.01, respectively), excretion of sodium (control, from 79.2 +/- 21.6 to 332.8 +/- 70.9-mu-Eq/min; CHF, from 77.4 +/- 20.8 to 753.5 +/- 108.0-mu-Eq/min; p < 0.01, respectively), and excretion of chloride (control, from 72.5 +/- 18.4 to 256.0 +/- 43.3-mu-Eq/min; CHF, from 74.0 +/- 19.6 to 708.8 +/- 103.3-mu-Eq/min; p < 0.01, respectively). Urinary excretion of sodium and of chloride in response to BNP infusion was higher in patients with CHF than in control subjects (p < 0.01, respectively). BNP infusion increased the levels of plasma atrial natriuretic peptide (control, from 65 +/- 11 to 84 +/- 14 pg/ml; CHF, from 262 +/- 65 to 301 +/- 62 pg/ml; p < 0.05, respectively) and decreased plasma aldosterone concentrations in both groups (control, from 43.3 +/- 12.1 to 27.3 +/- 7.1 pg/ml; CHF, from 91.1 +/- 34.3 to 66.3 +/- 27.2 pg/ml; p < 0.05, respectively). Conclusions. We conclude that BNP infusion improves left ventricular function in patients with CHF by vasodilation and prominent natriuretic action.
引用
收藏
页码:1581 / 1588
页数:8
相关论文
共 50 条
[21]   NEW NEUROHORMONAL ANTAGONISTS AND ATRIAL-NATRIURETIC-PEPTIDE IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE [J].
ABRAHAM, WT .
CORONARY ARTERY DISEASE, 1994, 5 (02) :127-136
[22]   ACE INHIBITORS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND RENAL DYSFUNCTION [J].
HEIDLAND, A ;
TESCHNER, M ;
GOTZ, R .
KLINISCHE WOCHENSCHRIFT, 1991, 69 :65-74
[23]   HEMODYNAMIC AND NEUROENDOCRINE CHANGES IN THE DEVELOPMENT OF CONGESTIVE-HEART-FAILURE [J].
SCHMIEDER, RE .
ACTA MEDICA AUSTRIACA, 1992, 19 (03) :77-82
[24]   DOPAMINERGIC DRUGS IN CONGESTIVE-HEART-FAILURE - HEMODYNAMIC AND NEUROENDOCRINE RESPONSES TO IBOPAMINE, DOPAMINE, AND DIHYDROERGOTOXINE [J].
METRA, M ;
MISSALE, C ;
SPANO, PF ;
CAS, LD .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (05) :732-740
[25]   HORMONAL CHANGES IN PATIENTS WITH SEVERE CHRONIC CONGESTIVE-HEART-FAILURE TREATED BY ULTRAFILTRATION [J].
FORSLUND, T ;
RIDDERVOLD, F ;
FAUCHALD, P ;
TORVIK, D ;
FYHRQUIST, F ;
SIMONSEN, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (04) :306-310
[26]   ACUTE HEMODYNAMIC-EFFECTS OF ENOXIMONE AND CAPTOPRIL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
SCHOLZ, M ;
KNEISSL, GD ;
DIETERICH, HA ;
KALTENBACH, M ;
BUSSMANN, WD .
ZEITSCHRIFT FUR KARDIOLOGIE, 1991, 80 :69-74
[27]   HEMODYNAMIC EVALUATION OF 2 REGIMENS OF MOLSIDOMINE IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
LEHMANN, G ;
REINIGER, G ;
BEYERLE, A ;
ZEITLER, H ;
RUDOLPH, W .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (02) :109-114
[28]   Usefulness of the percentage of plasma lymphocytes as a prognostic marker in patients with congestive heart failure - Comparison with brain natriuretic peptide [J].
Sakatani, T ;
Hadase, M ;
Kawasaki, T ;
Kamitani, T ;
Kawasaki, S ;
Sugihara, H .
JAPANESE HEART JOURNAL, 2004, 45 (02) :275-284
[29]   Cortical Brain Connectivity and B-Type Natriuretic Peptide in Patients With Congestive Heart Failure [J].
Vecchio, Fabrizio ;
Miraglia, Francesca ;
Valeriani, Lavinia ;
Scarpellini, Maria Gabriella ;
Bramanti, Placido ;
Mecarelli, Oriano ;
Rossini, Paolo M. .
CLINICAL EEG AND NEUROSCIENCE, 2015, 46 (03) :224-229
[30]   ATRIAL-NATRIURETIC-PEPTIDE IN CONGESTIVE-HEART-FAILURE AFTER ACUTE MYOCARDIAL-INFARCTION [J].
SVANEGAARD, J ;
ANGELONIELSEN, K ;
PINDBORG, T .
CARDIOLOGY, 1993, 82 (01) :1-6